Post-transplantation cyclophosphamide (Cy) as a single agent for GVHD prophylaxis after HLA matched related and unrelated bone marrow transplantation

被引：0
|
作者：
Luznik, L [1 ]
Chen, A [1 ]
Fuchs, EJ [1 ]
Phelps, M [1 ]
Crawford, A [1 ]
Brodsky, RA [1 ]
Huff, CA [1 ]
Jones, RJ [1 ]
机构：
[1] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2006年 / 12卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2005.11.081
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
65
引用
收藏
页码：26 / 26
页数：1
相关论文
共 50 条
  • [21] Post-Transplantation Cyclophosphamide for Gvhd Prophylaxis in Related and Unrelated Allogeneic Hematopoietic Cell Transplantation: Study from the SFGM-TC Registry
    Michallet, Mauricette
    Coman, Tereza
    Morisset, Stephane
    Sobh, Mohamad
    Devillier, Raynier
    Yakoub-Agha, Ibrahim
    Forcade, Edouard
    Maertens, Johan A.
    Bourhis, Jean-Henri
    Poire, Xavier
    Labussiere, Helene
    Chevallier, Patrice
    Chalandon, Yves
    Fegueux, Nathalie
    Huynh, Anne
    Dulery, Remy
    Quoc, Stephanie Nguyen
    Dalle, Jean-Hugues
    Bulabois, Claude-Eric
    Mear, Jean-Baptiste
    Rubio, Marie-Therese
    Raus, Nicole
    Robin, Marie
    BLOOD, 2021, 138
  • [22] Nonmyeloablative, HLA-haploidentical bone marrow transplantation with high dose, post-transplantation cyclophosphamide
    Munchel, Ashley
    Kesserwan, Chimen
    Symons, Heather J.
    Luznik, Leo
    Kasamon, Yvette L.
    Jones, Richard J.
    Fuchs, Ephraim J.
    PEDIATRIC REPORTS, 2011, 3 : 43 - 47
  • [23] Low incidence of CMV reactivation and infection after allogeneic bone marrow transplantation (BMT) incorporating post-transplantation cyclophosphamide (Cy).
    Symons, Heather J.
    Luznik, Leo
    Phelps, Michele
    Crawford, Angelita
    McIntyre, Katherine
    Levy, M. Yair
    Jones, Richard J.
    Fuchs, Ephraim J.
    BLOOD, 2006, 108 (11) : 809A - 810A
  • [24] Comparison of Outcomes after Haploidentical Relative and HLA Matched Unrelated Donor Transplantation with Post-Transplant Cyclophosphamide Containing Gvhd Prophylaxis Regimens
    Gooptu, Mahasweta
    Martin, Andrew St.
    Romee, Rizwan
    Arora, Mukta
    Al Malki, Monzr M.
    Antin, Joseph H.
    Bredeson, Christopher
    Brunstein, Claudio G.
    Chhabra, Saurabh
    Fuchs, Ephraim J.
    Ghosh, Nilanjan
    Grunwald, Michael R.
    Inamoto, Yoshihiro
    Kanakry, Christopher G.
    Kekre, Natasha
    McGuirk, Joseph P.
    McNiece, Ian K.
    Mehta, Rohtesh S.
    Mielcarek, Marco Last
    Milano, Filipo
    Modi, Dipenkumar
    Reshef, Ran
    Schroeder, Mark A.
    Soiffer, Robert J.
    Solomon, Scott R.
    Waller, Edmund K.
    Eapen, Mary
    BLOOD, 2020, 136
  • [25] Comparison of Outcomes After Haploidentical Relative and HLA Matched Unrelated Donor Transplantation With Post-Transplant Cyclophosphamide Containing GVHD Prophylaxis Regimens
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (02) : 18 - 19
  • [26] Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide
    McCurdy, Shannon R.
    Kasamon, Yvette L.
    Kanakry, Christopher G.
    Bolanos-Meade, Javier
    Tsai, Hua-Ling
    Showel, Margaret M.
    Kanakry, Jennifer A.
    Symons, Heather J.
    Gojo, Ivana
    Smith, B. Douglas
    Bettinotti, Maria R.
    Matsui, William H.
    Dezern, Amy E.
    Huff, Carol Ann
    Borrello, Ivan
    Pratz, Keith W.
    Gladstone, Douglas E.
    Swinnen, Lode J.
    Brodsky, Robert A.
    Levis, Mark J.
    Ambinder, Richard F.
    Fuchs, Ephraim J.
    Rosner, Gary L.
    Jones'and, Richard J.
    Luznik, Leo
    HAEMATOLOGICA, 2017, 102 (02) : 391 - 400
  • [27] Use of G-CSF Mobilized Bone Marrow Grafts in HLA-haploidentical Bone Marrow Transplantation (BMT) with Post-transplantation Cyclophosphamide (PT-Cy) Decreases Risk of Severe Acute GVHD
    Durakovic, Nadira
    Peric, Zinaida
    Desnica, Lana
    Grubic, Zorana
    Romic, Lucija
    Serventi-Seiwerth, Ranka
    Vrhovac, Radovan
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 707 - 708
  • [28] Correction to: A phase II study of post‑transplant cyclophosphamide combined with tacrolimus for GVHD prophylaxis after HLA‑matched related/unrelated allogeneic hematopoietic stem cell transplantation
    Hirohisa Nakamae
    Takahiko Nakane
    Hiroshi Okamura
    Hideo Koh
    Yasuhiro Nakashima
    Asao Hirose
    Mika Nakamae
    Mitsutaka Nishimoto
    Masatomo Kuno
    Yosuke Makuuchi
    Naonori Harada
    Teruhito Takakuwa
    Masayuki Hino
    International Journal of Hematology, 2022, 115 : 146 - 146
  • [29] Single-Agent Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis after Human Leukocyte Antigen-Matched Related Bone Marrow Transplantation for Pediatric and Young Adult Patients with Hematologic Malignancies
    Jacoby, Elad
    Chen, Allen
    Loeb, David M.
    Gamper, Christopher J.
    Zambidis, Elias
    Llosa, Nicolas J.
    Huo, Jeffrey
    Cooke, Kenneth R.
    Jones, Rick
    Fuchs, Ephraim
    Luznik, Leo
    Symons, Heather J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (01) : 112 - 118
  • [30] Post-transplantation cyclophosphamide (Cy) reduces graft rejection and graft-versus-host disease (GVHD) after non-myeloablative, partially HLA-mismatched (haploidentical) bone marrow transplantation (BMT)
    Fuchs, EJ
    Lunzik, L
    Chen, AR
    Phelps, M
    Crawford, A
    Brodsky, RA
    Jones, RJ
    BLOOD, 2004, 104 (11) : 128A - 128A
12345